Magnetoencephalography (MEG) is a non-invasive technique used to measure and record the brain’s electrical activity. It uses highly sensitive superconducting detectors to measure and monitor the magnetic fields produced by the electrical currents of the brain. This technology is used to measure electrical brain activity with accuracy and precision without invasively inserting any electrical probes or wires into the brain. It is non-invasive and therefore, carries no risk of trauma or infection. MEG can be used to identify electrical sources and pathways in the brain. This enables physicians to diagnose neurological and psychiatric disorders such as Alzheimer's, epilepsy, and autism. MEG can also help scientists further understand brain mechanisms and functions associated with perception, motor control, language processing, learning, and memory. Recent advances in MEG have given scientists better tools to study brain function. The newest technology uses sophisticated computer-based signal processing algorithms to capture and analyze the brain’s activity with high accuracy. This provides researchers with a powerful way to observe the activity within different areas of the brain. MEG can also be used to monitor the effects of drugs and treatments on the brain and can be used to optimize and personalize patient care. For instance, recently, a study showed that MEG was helpful in determining the most effective medication for treating epilepsy. In conclusion, MEG is a revolutionary technology that has enabled scientists and medical professionals to study and observe the brain’s electrical activity accurately and precisely.
Title : Spring break: A true story of hope and determination
Steven Benvenisti, Davis, Saperstein Salomon, PC, United States
Title : The role of compromised cerebrospinal fluid circulation in sleep apnea
Joe Sam Robinson, Mercer University, United States
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Nervous system effects in chemicals with immediately dangerous to life or health values
Sudha P Pandalai, National Institute for Occupational Safety and Health, United States
Title : Clinical outcomes of AI-augmented cognitive rehabilitation in dementia and mild cognitive impairment
Esra Al, NewDays, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States